Pfizer, Flynn Pharma fined by UK antitrust court over epilepsy-drug pricing behaviors
MLex Summary: Pfizer has been fined 62 million pounds and Flynn Pharma fined 6.7 million pounds by the UK competition court over epilepsy-drug pricing behaviors, with the sanctions largely matching those...To view the full article, register now.
Already a subscriber? Click here to view full article